Influenza virus characterisation - Summary Europe, May 2020
This is the seventh report for the 2019 2019–20 influenza season. As of week 20 / 16 4 868 influenza detections across the WHO European Region ha have been reported; 73% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 27% type B viruses, with 4 4 479 (98%) of 4 5 568 ascribed to a lineage being B/Victoria.
Methodology for estimating point prevalence of SARS-CoV-2 infection by pooled RT-PCR testing
The methodology presented in this document provides a way to efficiently estimate COVID-19 prevalence by analysing the results of pooled RT-PCR tests, without the need to identify individual test results. The statistical foundation of the methodology is explained in detail.
Influenza virus characterisation, summary Europe, April 2020
ECDC’s influenza virus characterisation reports are published periodically and give an overview of circulating influenza viruses. They provide details on the current vaccine strains, summarise the development of the viruses since the last report, and closely follow the main developments for the ongoing influenza season. Virus characterisation reports are primarily intended for influenza virologists and epidemiologists.
Ninth external quality assessment scheme for Salmonella typing
ECDC is supporting a large number of targeted External Quality Assessment (EQA) schemes with voluntary participation by reference or primary laboratories, which are active members of EU surveillance networks.
An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA
According to EU recommendations, timely and accurate COVID-19 laboratory testing is an essential part of the management of COVID-19 for slowing down the pandemic, supporting decisions on infection control strategies and patient management at healthcare facilities, and detecting asymptomatic cases that could spread the virus further if not isolated.
Proficiency test for Listeria monocytogenes whole genome assembly 2018
This report presents the results of a proficiency test to evaluate the inter-laboratory reproducibility and portability of Listeria monocytogenes (Lm) genome assemblies in the EU/EEA.
Lymphogranuloma venereum (LGV) in men who have sex with men (MSM): A re-emerging problem, Malta, 2018
Donachie, A., Spiteri, G., Barbara, C., Melillo, T., Hadad, R., Farrugia, A.G., Unemo, M., Padovese, V.
Handbook on tuberculosis laboratory diagnostic methods in the European Union - Updated 2018
This handbook provides network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis.
Yellow fever in the diagnostics laboratory review-article
Domingo, C., Charrel, R.N., Schmidt-Chanasit, J., Zeller, H., Reusken, C.
Laboratory testing of non-partner sperm donors
The European Centre for Disease Prevention and Control was asked by the European Commission to assess the risk involved in changing the testing requirements for HIV (human immunodeficiency virus), hepatitis B virus (HBV), and hepatitis C virus (HCV) with regard to the quality and safety of non-partner semen donations.